NCD Japan Forum 2011
date : 11/29/2011

On the 29th September 2011, the Health and Global Policy Institute hosted the “NCD Forum 2011 ~ Chronic Disease Control and the NCD Agenda in Developed Countries” at the Ambassador’s Residence of the British Embassy in Tokyo.
In September, the importance of tackling non-communicable diseases (NCDs; or chronic diseases) was highlighted to the world as it became the main topic of discussion at the U.N. High Level Meeting. This forum was therefore held with a view to reminding the participants of this important issue, whilst also providing a platform for the discussion of future NCD control strategies within Japan, the sharing of perspectives and ambitions of various stakeholders in this field, and the exchange of views on the future measures to be taken by Japan.
Japan has a record of making significant contributions to infectious disease control in its role as a major donor to the U.N. In light of its knowledge in dealing with chronic disease, it is also expected that it will exert international initiative in the area of NCDs.
The Forum was opened with greetings from H.M. Ambassador David Warren and a keynote speech from Dr. Keizo Takemi, Professor at the School of Political Science and Economics at Tokai University and Senior Fellow at the Japan Center for International Exchange. This was then followed by presentations from Ms. Judith Watt, Strategic Consultant to the NCD Alliance (an international collaborative organization dealing with NCD issues), and Dr. Hajime Inoue, Director of the Department of Health and Welfare in Chiba Prefecture. Under the title “What are NCDs? – Implications for Japan and its Global Role”, Ms. Watt and Dr. Inoue served to both provide an introduction to, and also to deepen the audiences’ understanding of the current situation with NCDs.
In the latter half of the Forum, a panel discussion took place with a further four experts (Dr. Ryozo Nagai, Department of Cardiovascular Medicine, The University of Tokyo; Dr. Masato Mugitani, Assistant Minister for Global Health, Ministry of Health and Welfare; Mr. David Brennan, President, International Federation of Pharmaceutical Manufacturers & Associations (IFPMA); Ms. Loyce Pace, Director of Health Policy, Lance Armstrong Foundation), under the theme of “The Roles that should be Played by Different Sectors – Global Partnerships for NCD and Beyond”. In their positions as representatives of the different stakeholders in the NCD issue, each panelist shared their thoughts on the future contributions that can be made and the initiatives that should be undertaken from their varying perspectives. The panelists also further engaged in lively discussion and an exchange of views as to how the knowledge Japan has accumulated thus far in health policy can benefit the rest of the world in the NCD field, and the contributions it could make.
Exhibition date:2011-11-29
Top Research & Recommendations Posts
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Public Comment Submission] “GX2040 Vision (Draft)” (January 26, 2025)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Public Comment Submission] “Third Phase of The Healthcare Policy (Draft)” (February 3, 2025)
- [Public Comment Submission] “Plan for Global Warming Countermeasures (Draft)” (January 26, 2025)
- [Publication Report] Guidance on Patient and Public Involvement (PPI) in Health Policymaking: Necessary Initiatives and Good Examples from the Public and Government (March 31, 2024)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Policy Recommendations] Achieving a Sustainable Society of Health and Longevity Through the Integration of Environment and Healthcare-Incorporating a Planetary Health Perspective into the 3rd Phase of The Healthcare Policy-(December 20, 2024)
Featured Posts
-
2025-02-12
[Registration Open] (Webinar) The 131st HGPI Seminar “The Policy Process of the Kyoto City Caregiver Ordinance” (March 19, 2025)
-
2025-02-20
[Registration Open] The Cardiovascular Disease (CVD) Control Promotion Project Online Global Symposium “Exploring the Future of CVD Control Through Policy Case Studies in the Asia-Pacific Region” (March 13, 2025)
-
2025-03-03
[Registration Open] (Webinar) HGPI Special Seminar “Insights from Harvard Students on Fukushima’s Recover” (March 21, 2025 EDT | March 22, 2025 JST)
-
2025-03-13
[HGPI Policy Column] (No.54) From the Kidney Disease Control Promotion Project “The Promotion of Kidney Disease Measures Through Multi-Stakeholder Collaboration”
-
2025-03-13
[HGPI Policy Column] (No.55) From the Kidney Disease Control Promotion Project “What Is Required from a Patient Perspective for Continuity of Treatment for Chronic Kidney Disease (CKD): Dietary Therapy Edition”